FDA Investigates Adverse Events Reported With Da Vinci Robot
This article was originally published in The Gray Sheet
Executive Summary
An apparent increase in adverse event reports with Intuitive Surgical’s popular robotic surgery system has triggered further inquiry from FDA.
You may also be interested in...
Surgical Robot Regs To Be Addressed At FDA Gathering
The agency plans to tackle major issues related to robotically-assisted surgical devices such as safety and efficacy requirements as well as proper surgical training in what it describes is a “rapidly-developing field” during a two-day summer workshop.
MIS 2014, Part 2: Opportunities And Challenges
The increasing prevalence of MIS and the opportunity for greater MIS penetration in existing procedures translate into significant growth potential for the MIS products market in the years ahead. Despite some challenges, device manufacturers are driving growth in the market by targeting key procedures and geographies with new robotic surgery systems and robotic-like technologies designed to enable more complex procedures to be performed via an MIS approach.
Intuitive Looks To da Vinci Upgrades, Emerging Markets To Fuel Turnaround
Surgical robot-maker Intuitive Surgical reported slowing procedure growth in the U.S. in the first quarter. The company is looking to new technology and expansion into emerging international markets going forward.